ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Geriatric Medicine

Top Geriatric Medicine Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ERIC BARNES D.O.

Geriatric Medicine

68,611

$5.98M

1248
627 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$87
Average prescription price

Avg: $61

DAVID CARR MD

Geriatric Medicine

1,446

$122K

121
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$85
Average prescription price

Avg: $61

WIT JAMRY MD

Geriatric Medicine

30,529

$2.43M

482
333 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

22%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 24%

$79
Average prescription price

Avg: $61

SHELLEY ALEXANDER D.O.

Geriatric Medicine

5,381

$399K

161
56 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $61

BRUCE LOWRIE MD

Geriatric Medicine

3,656

$260K

148
121 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $61

RAFI KEVORKIAN MD

Geriatric Medicine

15,047

$1.05M

402
242 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $61

JON DEDON M.D.

Geriatric Medicine

13,178

$918K

183
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $61

CHARLES CRECELIUS M.D.

Geriatric Medicine

16,844

$1.17M

557
530 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $61

ELLEN BINDER MD

Geriatric Medicine

2,280

$156K

82
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $61

YELENA MELYAKOVA M.D.

Geriatric Medicine

1,873

$125K

224
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $61

ASIF BHUTTO M.D.

Geriatric Medicine

3,303

$218K

179
153 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $61

JULIE GAMMACK MD

Geriatric Medicine

1,783

$115K

108
94 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $61

ABRAHAM BARAKE M.D.

Geriatric Medicine

7,023

$450K

442
411 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $61

MOHAMMED MOJID M.D.

Geriatric Medicine

17,755

$1.1M

518
342 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

23%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $61

DEATRICE KELLOGG MD

Geriatric Medicine

27,690

$1.7M

732
639 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $61

JOSEPH FLAHERTY MD

Geriatric Medicine

5,890

$358K

215
205 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $61

JOHN MORLEY MD

Geriatric Medicine

12,908

$778K

396
339 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $61

KATHLEEN SPROULES D.O.

Geriatric Medicine

3,376

$201K

103
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $61

RICHARD ONEILL M.D.

Geriatric Medicine

11,752

$690K

496
384 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $61

DULCE CRUZ OLIVER MD

Geriatric Medicine

3,358

$195K

136
121 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

RAJAMANICKAM PURUSHOTHAMAN MD

Geriatric Medicine

14,089

$813K

455
401 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

PETER HOLT MD

Geriatric Medicine

18,894

$1.09M

859
832 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

ANNE EGBERT M.D.

Geriatric Medicine

1,335

$74.8K

200
189 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $61

SEEMA IYER M.D.

Geriatric Medicine

5,618

$314K

458
341 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $61

POONAM JAIN M.D.

Geriatric Medicine

10,527

$584K

237
227 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank